HOYA to invest in InnFocus, Inc., a new glaucoma device company. InnFocus also announced that it received authorization from the FDA to begin Phase I trial of the InnFocus MicroShunt™ to treat open angle glaucoma.
HOYA Surgical Optics announced that it has completed the installation and validation of new equipment at its factory in Singapore and resumed manufacturing of the 1-Piece IOLs that were voluntarily recalled.
HOYA Surgical Optics, Inc. (HSO) announced today that they have received approval from the FDA to commercially distribute two models of clear foldable hydrophobic acrylic‐optic aspheric intraocular lenses; the iSymm™ Intraocular Lens (Model FC‐60AD) and the preloaded iSert™ Intraocular Lens (Model PC‐60AD) in the U.S.
HOYA Surgical Optics and Tracey Technologies, Inc. announced the introduction of a new system for cataract surgeons that incorporates the latest version of the proven HOYA iSert® aspheric hydrophobic IOL together with the most advanced iTrace™ system ever developed, the HOYA iTrace™ Surgical Workstation.
HOYA Surgical Optics announced record results for their business in 2010 and a global optimization plan for 2011. The 2010 business results were achieved based on growth of their intraocular lens business in all sales regions: Japan, Asia/Pacific, the Americas, and EMEA. The new globalization plan that begins this month will result in a realignment of functions and departments and a move of the company’s headquarters to Singapore.
HOYA Surgical Optics today announced that the Centers for Medicare and Medicaid Services (CMS) has added the Blue Light Absorbing iSymm Aspheric Lens from Hoya Surgical Optics to the New Technology Intraocular Lens (NTIOL) class for IOLs with Reduced Spherical Aberration.
The NTIOL designation indicates that the iSymm lens has been proven to provide subset-specific clinical benefits and is approved for $50 additional Medicare payment in conjunction with cataract procedures performed in ambulatory surgical centers under the HCPCS code Q1003.
HOYA Surgical Optics Germany is proud to announce its first scientific Awards that will bring together outstanding young German ophthalmologists in recognition of their work in cataract and IOL refractive surgery. The winner will be announced by Prof. Gerd Auffarth, President of the German speaking Society of Intraocular Lenses Implantation (DGII), during the next DGII Congress which will take place in Bochum on 7th of March.
HOYA Surgical Optics Awards in Germany supports research in the following categories:
Clinically oriented innovations and studies in the field of refractive surgery and cataract surgery
Others research and work projects in the field of refractive surgery and cataract surgery such as social engagement in poor countries.
The winner, as chosen by the jury (Administration Board of the DGII), will be awarded a price of 5,000€.
For further information concerning the HOYA Surgical Optics Germany Award 2014, please contact HOYA Surgical Optics GmbH at ifra-info@HOYA.com
HOYA Surgical Optics is proud to hold its second annual Scientific Awards competition, recognizing good science and providing young Austrian surgeons with further experience in presenting information to scientists.
For the first time HOYA Surgical Optics will be sponsoring the Poster Prize Awards at the SFO (French Society of Ophthalmology)-Congress which will take place on May 11th -14th 2013. The Theme of the poster communication is “Cataract Surgery”. The winner, as chosen by the jury, will be awarded a price of 6,000 € and second prize is 4,000€.
Rules and conditions
How to participate:
The author should be an ophthalmologist or should have a DES-Certificate
The author should be a SFO active member, be not older than 35 years and live in France
The poster must be presented in English or French
tecniques of investigation about the cataracte surgery or about IOL
the innovation aspect of the presentation
the accuracy of the poster content
the clarity of the exposed subject
respect to the medical ethical rules and protection of personal data
all the posters for commercial porposes are excluded from this selection
7 experts membres of the Administration Board of the SFO
HOYA Surgical Optics announced that it has received higher than expected reported rates of inflammation and/or endophthalmitis from doctors using iSert® 250, iSert® 251, and NY-60 IOLs in a few countries.
HOYA Surgical Optics announced today the opening of its new global headquarters in Singapore. In an open house launch event at the new headquarters attended by ophthalmologists, business partners, and local officials, Thomas A. Dunlap, President and CEO of HOYA Surgical Optics, said: “Our business has grown rapidly and become more globally integrated.”